Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-procedure enoxaparin dosing after elective endovascular treatment of unruptured intracranial aneurysm
ACTRN12620001128987Phase 2Recruiting
- Sponsor
- Professor Alan Coulthard
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of enoxaparin in brain aneurysm (IA) (2 arms), sponsored by Professor Alan Coulthard. Started Feb 2021; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ACTRN12620001128987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001128987.